Gesundheit, Arzneimittel, Wohlfahrtsökonomik, Extra-Welfarismus. - Since 1961 access to market for innovative pharmaceuticals was increasingly regulated. The first step was a simple registration procedure, followed by federal licensing in 1978. Since 1989 the licensing was complemented by price...

Research on the launch of new products in the international realm is scarce. The present paper is the first to document how launch window (difference in months between the first worldwide launch and the subsequent launch in a specific country) and launch price are interrelated and how regulation...

Consider a firm that is developing an innovative product. We study the trade-offs associated with its product design decisions in regards to product performance (the function of the product), product reliability (whether the product will perform its function) and product time-to-market (the...